Pulmonary Hypertension in Left Heart Disease and Chronic Right Ventricular Failure [0.03%]
左心病和慢性右心室衰竭所致肺动脉高压
HangYu Watson,Bansari Patel,Marco Caccamo
HangYu Watson
Pulmonary hypertension due to left heart disease (PH-LHD) is a common yet complex condition characterized by elevated left atrial pressure, leading to postcapillary pulmonary hypertension. It is divided into isolated postcapillary PH and co...
Rachel Tobin,Petra Rantanen,Melissa Lyle et al.
Rachel Tobin et al.
Heart failure (HF) comorbidities are extremely common and complicate management due to increased prescriptions and adverse drug effects, declining functional status, and more frequent health care utilization. Comorbidities are associated wi...
Vikas Yellapu,Patrick Field,Purujit Thacker et al.
Vikas Yellapu et al.
This review examines the role of diagnostic and prognostic testing in heart failure. It discusses the use of biomarkers, genetic testing, and advanced imaging techniques, such as echocardiography and cardiac MRI, for heart failure diagnosis...
Worsening Heart Failure [0.03%]
心力衰竭加重
Alison L Bailey,Nilay Sutaria
Alison L Bailey
Worsening heart failure is a common cause of morbidity and mortality among patients worldwide. It is important to recognize changes in a patient's clinical care to understand the risk to their cardiovascular health and overall well-being. E...
Muling Lin,Sanjay Amrith Chandrasekhar,Andrew Pistner
Muling Lin
Chronic heart failure is characterized by periods of stability punctuated by clinical decline often requiring hospitalization. Following hospitalization, patients remain at an increased risk of morbidity and mortality, often requiring rehos...
Aaron Scott Gillet,Garrick C Stewart
Aaron Scott Gillet
Heart failure (HF) mortality rates have been increasing in the United States since 2012, with disproportionate increases in those aged under 65 years and in individuals who identify as Black. Expanded medical and device therapies across the...
Lauren D Spaeth,Muhammed Rahim,Ajar Kochar et al.
Lauren D Spaeth et al.
Cardiogenic shock is a complex clinical syndrome primarily resulting from acute myocardial infarction or decompensated heart failure, though other less common causes exist. It is characterized by hypotension, reduced organ perfusion, and di...
Satoshi Shoji,Martin Osorio Nader,Robert J Mentz
Satoshi Shoji
Loop diuretics are Class I recommended for managing congestion in chronic heart failure, though their effect on morbidity and mortality remains uncertain due to limited large-scale evidence. Current guidelines recommend using the lowest eff...
Dusty L Lisi,Kira Gaddis,Mahmoud H Abdou
Dusty L Lisi
Pharmacotherapy for heart failure (HF) with reduced ejection fraction (HFrEF) is the foundation of management. The basis of pharmacotherapy for HFrEF includes 4 pillars: beta-blockers, renin angiotensin aldosterone system modulators, minera...
Michelle M Kittleson,Leah M Raj,Dustin T Smith
Michelle M Kittleson
Hospitalizations for decompensated heart failure confer significant morbidity, mortality, and health care costs. There are multiple clinical trials, which offer strong evidence that medications and interventions improve outcomes; however, h...